icon-folder.gif   Conference Reports for NATAP  
 
  17th European AIDS Conference
November 6-9
2019, Basel
Back grey_arrow_rt.gif
 
 
 
DISCOVER in Europe: a Subanalysis of the Phase 3, Randomized, Controlled Trial of Daily Emtricitabine/Tenofovir Alafenamide or Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Pre-exposure Prophylaxis
 
 
  17th European AIDS Conference (EACS), 6-9 November 2019, Basel, Switzerland Reported by Jules Levin
 
Frank Post,1 Christoph Spinner,2 Pep Coll,3 Trevor Hawkins,4 Jonathon Anderson,4 Lijie Zhong,4 Scott McCallister4
1King's College Hospital, London, UK; 2Klinikum rechts der Isar, Technische Universität München Fakultät für Medizin, München, Germany; 3BCN Checkpoint, IrsiCaixa AIDS Institut de Recerca de la Sida, Barcelona, Spain; 4Gilead Sciences, Inc., Foster City, California, USA

1112191

1112192

1112193

1112194

1112195

1112196

1112197

References: 1. Descovy [package insert]. Foster City, CA: Gilead Sciences, Inc.: 10/2019; 2. Hare CB, et al. CROI 2019. abstr 104; 3. Hayes R, et al. Euro Surveillance. 2019 Oct;24.